VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $10,000.00 income · posted Apr 14, 2026

Lobbying activity 1

Budget/Appropriations

FY 2026 & FY 2027 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases; FY 2026 & FY 2027 global health research and development funding; Issues related to global health.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.